The Western States Scientific Safety Review Workgroup completed its review of the federal process and has unanimously concluded that the Pfizer-BioNTech and Moderna vaccines are safe and effective for children as young as 6 months old. The Workgroup provided its confirmation to the Governors of California, Nevada, Oregon, and Washington. The Moderna two-dose vaccine series and the Pfizer three-dose vaccine series are now available to children as young as 6 months old. The Oregon Health Authority will inform health care providers that vaccinations for children as young as 6 months old can begin in Oregon as soon as Monday. On Friday, June 17, the U.S. Food and Drug Administration (FDA) authorized the use of the vaccines in children as young as 6 months old, and the CDC affirmed that decision on Saturday. The Workgroup reviewed the federal decisions on Saturday and affirmed them Wednesday. The Workgroup thoroughly reviewed safety and efficacy data for the vaccines. The Workgroup found that completion of either vaccine series produced antibody levels similar to those achieved in individuals aged 16-25 years. Observed vaccine reactions among infants aged 6-12 months and children aged 1 through 5 years were consistent with reactions to other vaccines routinely recommended for these age groups. The Workgroup concluded that the benefits of completing either vaccine series substantially outweigh any known or likely risks. Immunization can be expected to reduce the numbers of COVID-19-related serious illnesses, hospitalizations, and deaths in young children while facilitating their participation in normal educational, social and recreational activities. Vaccines for ages 6 months and up are available at Coos Health & Wellness. For appointments, go to our website, cooshealthandwellness.org or call 541-266-6700.